|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
2003-6-2
|
|
pubmed:abstractText |
Platelet glycoprotein IIb/IIIa inhibitors have significantly reduced the incidence of 30-day ischemic events during percutaneous coronary interventions (PCI). However, each of the three currently available agents has different pharmacological characteristics, safety, efficacy and costs. There has not been a direct comparison between eptifibatide and abciximab in the rates of major adverse cardiac events, major complications and thrombocytopenia.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
1042-3931
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
15
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
319-23
|
|
pubmed:dateRevised |
2010-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:12777670-Aged,
pubmed-meshheading:12777670-Angina, Unstable,
pubmed-meshheading:12777670-Angioplasty, Balloon, Coronary,
pubmed-meshheading:12777670-Antibodies, Monoclonal,
pubmed-meshheading:12777670-Chi-Square Distribution,
pubmed-meshheading:12777670-Cohort Studies,
pubmed-meshheading:12777670-Coronary Restenosis,
pubmed-meshheading:12777670-Coronary Stenosis,
pubmed-meshheading:12777670-Female,
pubmed-meshheading:12777670-Follow-Up Studies,
pubmed-meshheading:12777670-Humans,
pubmed-meshheading:12777670-Immunoglobulin Fab Fragments,
pubmed-meshheading:12777670-Logistic Models,
pubmed-meshheading:12777670-Male,
pubmed-meshheading:12777670-Middle Aged,
pubmed-meshheading:12777670-Peptides,
pubmed-meshheading:12777670-Platelet Aggregation Inhibitors,
pubmed-meshheading:12777670-Platelet Glycoprotein GPIIb-IIIa Complex,
pubmed-meshheading:12777670-Probability,
pubmed-meshheading:12777670-Retrospective Studies,
pubmed-meshheading:12777670-Risk Assessment,
pubmed-meshheading:12777670-Thrombocytopenia,
pubmed-meshheading:12777670-Treatment Outcome
|
|
pubmed:year |
2003
|
|
pubmed:articleTitle |
Comparison of two platelet glycoprotein IIb/IIIa inhibitors, eptifibatide and abciximab: outcomes, complications and thrombocytopenia during percutaneous coronary intervention.
|
|
pubmed:affiliation |
Division of Invasive Cardiology, Department of Cardiology, Rambam Medical Center, Haifa-31096, Israel. gruberg67@hotmail.com
|
|
pubmed:publicationType |
Journal Article,
Comparative Study
|
